Smoking cessation

Conversio Health Delivers Improved Patient Outcomes and Reduced Costs with Groundbreaking COPD and Asthma Disease Management Program

Retrieved on: 
Thursday, February 8, 2024

SAN LUIS OBISPO, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Conversio Health, the leading innovator in respiratory disease care, today announced the success of its pioneering COPD and Asthma disease management program—significantly improving patient outcomes and reducing costs for patients and healthcare stakeholders. Their program has grown rapidly over the past 18 months, consistently partnering with new provider groups and health plans. The Conversio Health chronic respiratory management program delivers the most comprehensive patient care solution:

Key Points: 
  • New website for Conversio's disease management program highlights significant improvements in patient care and cost associated with chronic respiratory conditions.
  • SAN LUIS OBISPO, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Conversio Health, the leading innovator in respiratory disease care, today announced the success of its pioneering COPD and Asthma disease management program—significantly improving patient outcomes and reducing costs for patients and healthcare stakeholders.
  • Their program has grown rapidly over the past 18 months, consistently partnering with new provider groups and health plans.
  • The Conversio Health chronic respiratory management program delivers the most comprehensive patient care solution:
    Custom Nebulizer Medications: Improve drug delivery & lung penetration and provide cost savings to patients & health plans.

Pusan National University Researchers Decode the Link Between Smoking and Amyotrophic Lateral Sclerosis Risk

Retrieved on: 
Tuesday, January 30, 2024

This treatment gap highlights the need to identify risk factors, particularly modifiable ones, that could potentially prevent the onset of ALS.

Key Points: 
  • This treatment gap highlights the need to identify risk factors, particularly modifiable ones, that could potentially prevent the onset of ALS.
  • While smoking has been considered a significant risk, studies have yielded inconclusive results, failing to pinpoint the exact association.
  • Identifying smoking as a modifiable risk factor highlights the potential for mitigating the risk of developing ALS through smoking cessation.
  • Title of original paper: Association of smoking with amyotrophic lateral sclerosis: A systematic review, and meta-analysis, including dose-response analysis

Partnership-funded initiative has increased access to smoking cessation support for people with cancer

Retrieved on: 
Wednesday, January 24, 2024

For people with cancer, quitting smoking after a cancer diagnosis can make a big difference.

Key Points: 
  • For people with cancer, quitting smoking after a cancer diagnosis can make a big difference.
  • By quitting smoking, a person's cancer treatment becomes more effective and their chance of survival increases by about 40 per cent – making smoking cessation support a critical component of initial cancer treatment and high-quality cancer care.
  • When the Partnership began leading this pan-Canadian initiative to integrate evidence-based smoking cessation into cancer care across Canada, only two provinces were actively helping people with cancer quit smoking.
  • Impact of a Pan-Canadian Initiative, visit Smoking cessation in cancer care across Canada, 2022-23 – Canadian Partnership Against Cancer .

Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy

Retrieved on: 
Wednesday, November 29, 2023

Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced positive results from its first in-human study of QN-01, the company’s lead asset.

Key Points: 
  • Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced positive results from its first in-human study of QN-01, the company’s lead asset.
  • QN-01 is an inhaled smoking cessation therapy that is currently being evaluated in the U.S. under FDA’s Center for Drug Evaluation and Research (CDER) and in the U.K. by the Medicines and Healthcare Products Regulatory Agency (MHRA).
  • “We are delighted to share that QN-01 demonstrated a superior pharmacokinetic profile compared to an existing inhaled NRT and was well tolerated.
  • The drug-device combination was well tolerated with no severe adverse events and few minor adverse events typical of inhaled nicotine.

Corporate Wellness Market Size to Grow USD 73640 Million by 2029 at a CAGR of 5.5% | Valuates Reports

Retrieved on: 
Thursday, December 7, 2023

The Corporate Wellness Market is projected to grow from USD 53410 Million in 2023 to USD 73640 Million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Key Points: 
  • The Corporate Wellness Market is projected to grow from USD 53410 Million in 2023 to USD 73640 Million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
  • Claim Your Free Sample Now:
    Major Factors Driving the Growth of the Corporate Wellness Market:
    The Corporate Wellness Market is enjoying substantial expansion driven by a confluence of factors.
  • North America's corporate wellness market is expanding significantly due to increased attention to employee well-being, healthcare cost management, and technology improvements.
  • Particularly in the United States, there is a developed corporate wellness market with a high rate of program uptake.

Corporate Wellness Market Size to Grow USD 73640 Million by 2029 at a CAGR of 5.5% | Valuates Reports

Retrieved on: 
Thursday, December 7, 2023

The Corporate Wellness Market is projected to grow from USD 53410 Million in 2023 to USD 73640 Million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Key Points: 
  • The Corporate Wellness Market is projected to grow from USD 53410 Million in 2023 to USD 73640 Million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
  • Claim Your Free Sample Now:
    Major Factors Driving the Growth of the Corporate Wellness Market:
    The Corporate Wellness Market is enjoying substantial expansion driven by a confluence of factors.
  • North America's corporate wellness market is expanding significantly due to increased attention to employee well-being, healthcare cost management, and technology improvements.
  • Particularly in the United States, there is a developed corporate wellness market with a high rate of program uptake.

Military Roots Run Deep Through Family Care Center's Commitment to Breaking the Stigma Around Mental Health

Retrieved on: 
Thursday, November 9, 2023

DENVER, Nov. 8, 2023 /PRNewswire/ -- Every year, approximately 200,000 active-duty servicemen and women return to civilian life. Transitions for Veterans can be especially challenging due to shifting from the collective culture of military service to a more individualized role in society. In fact, studies indicate that 44% to 72% experience high levels of stress during the transition from military to civilian life.

Key Points: 
  • It's a growing concern, and it's the reason why Family Care Center continues its work to transform mental health care through its unique understanding of the military community.
  • "Our roots in providing expanded mental health care to the armed services came from a shared sense of duty, honor and dedication."
  • Family Care Center has worked to alleviate the challenges many Veterans encounter when trying to access mental health care.
  • To learn more about Family Care Center's comprehensive mental health services or to schedule an appointment, please visit https://fccwellbeing.com or call 888-374-5066.

Corporate Wellness Market size to grow by USD 29.20 billion from 2022 to 2027 | Aduro LLC, Central Corporate Wellness, ComPsych Corp., and more among the key companies in the market - Technavio

Retrieved on: 
Friday, November 3, 2023

The global corporate wellness market is fragmented, with the presence of several global as well as regional vendors.

Key Points: 
  • The global corporate wellness market is fragmented, with the presence of several global as well as regional vendors.
  • Central Corporate Wellness - The company offers corporate wellness programs such as corporate health screening, onsite vaccination programs, and corporate health talks.
  • By geography, the global corporate wellness market is segmented into North America, Europe, APAC, South America, and Middle East and Africa.
  • The US corporate wellness market size is estimated to grow at a CAGR of 8.38% between 2022 and 2027.

Ambetter from Sunshine Health Offers Health Insurance to 62 Counties Across Florida in 2024

Retrieved on: 
Thursday, November 2, 2023

FORT LAUDERDALE, Fla., Nov. 2, 2023 /PRNewswire/ -- Ambetter from Sunshine Health, a product offered by wholly owned subsidiaries of Centene Corporation (NYSE: CNC) which provide insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace, announced today that it will offer a variety of affordable health insurance plans to residents in 62 counties in Florida for 2024. Open enrollment for the Health Insurance Marketplace for Florida runs from Nov. 1, 2023, through Jan. 15, 2024. 

Key Points: 
  • Ambetter from Sunshine Health offers Florida residents a variety of affordable plans during Open Enrollment beginning Nov. 1
    FORT LAUDERDALE, Fla., Nov. 2, 2023 /PRNewswire/ -- Ambetter from Sunshine Health , a product offered by wholly owned subsidiaries of Centene Corporation (NYSE: CNC) which provide insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace, announced today that it will offer a variety of affordable health insurance plans to residents in 62 counties in Florida for 2024.
  • Open enrollment for the Health Insurance Marketplace for Florida runs from Nov. 1, 2023, through Jan. 15, 2024.
  • Ambetter from Sunshine Health offers its members access to quality care, convenient services and valuable rewards.
  • Ambetter from Sunshine Health and Walgreens are improving the affordability of health and wellness products for members in Florida.

National Lung Health Alliance to Lobby Parliament Hill: An Urgent Call to Prioritize Canadian Lung Health

Retrieved on: 
Tuesday, October 17, 2023

TORONTO, Oct. 17, 2023 /CNW/ - The Lung Health Foundation has spearheaded the formation of the National Lung Health Alliance (NLHA), a groundbreaking coalition of organizations committed to the urgent improvement of lung health across Canada.

Key Points: 
  • TORONTO, Oct. 17, 2023 /CNW/ - The Lung Health Foundation has spearheaded the formation of the National Lung Health Alliance (NLHA), a groundbreaking coalition of organizations committed to the urgent improvement of lung health across Canada.
  • The National Lung Health Alliance stands as a testament to the unity and shared purpose of various provincial and national associations.
  • Members of NLHA include: Alberta Lung, BC Lung Foundation, Lung Health Foundation, Lung NSPEI, Lung Sask, NB Lung and Association pulmonaire du Québec and national members Lung Cancer Canada, Asthma Canada and COPD Canada.
  • The Alliance, fostered by the efforts of the Lung Health Foundation, aims to illuminate the pressing nature of lung health issues, showcasing some areas of urgent concern.